BEN
36
4
ITW
45
2
IR
46
3
MTCH
62
22
ZBH
69
15
DOW
47
4
STT
48
4
FAST
41
7
PH
60
5
ROST
60
3
PBI
30
-8
IP
53
3
AAP
26
5
KEY
24
2
RL
73
5
LRCX
56
4
DE
49
3
WM
53
2
NEM
30
2
XEL
48
11
BEN
36
4
ITW
45
2
IR
46
3
MTCH
62
22
ZBH
69
15
DOW
47
4
STT
48
4
FAST
41
7
PH
60
5
ROST
60
3
PBI
30
-8
IP
53
3
AAP
26
5
KEY
24
2
RL
73
5
LRCX
56
4
DE
49
3
WM
53
2
NEM
30
2
XEL
48
11
Financhill
Back

Vinci Partners Investments Vs. Novo Nordisk AS Industry Stock Comparison

Sell
31

VINP
Vinci Partners Investments

Last Price:
$9.91
Seasonality Move:
4.32%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Sell
31
Vinci Partners Investments (VINP) is a Sell

Is Vinci Partners Investments a Buy, Sell or Hold?

  • The current Vinci Partners Investments [VINP] share price is $9.92. The Score for VINP is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • VINP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VINP Stock Price Chart

What is Vinci Partners Investments's stock price today?

  • The Vinci Partners Investments share price today is $9.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VINP is experiencing selling pressure, which indicates risk of future bearish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

VINP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 38.22 Sell
Chaikin Money Flow: -241863 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.08 - 10.58) Sell
Bollinger Bands (100): (9.9 - 10.76) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

VINP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.42 Sell
20-day SMA: 10.35 Sell
50-day SMA: 10.32 Sell
200-day SMA: 10.64 Sell
8-day EMA: 10.24 Sell
20-day EMA: 10.34 Sell
50-day EMA: 10.33 Sell
200-day EMA: 10.45 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

Vinci Partners Investments Earnings Growth & VINP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.30 per share, and an increase next year of $0.15 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

Vinci Partners Investments Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):